Singpanna Kanokwan, Jiratananan Puchapong, Paiboonwasin Santipharp, Petcharawuttikrai Nawinda, Chaksmithanont Prin, Pornpitchanarong Chaiyakarn, Patrojanasophon Prasopchai
Pharmaceutical Development of Green Innovations Group (PDGIG), Faculty of Pharmacy, Silpakorn University, Nakhon Pathom 73000, Thailand.
Department of Industrial Pharmacy, Faculty of Pharmacy, Silpakorn University, Nakhon Pathom 73000, Thailand.
Polymers (Basel). 2024 Oct 18;16(20):2930. doi: 10.3390/polym16202930.
Retinaldehyde (RAL), or retinal, is a vitamin A derivative that is widely used for several skin conditions. However, it is light sensitive and has low water solubility, limiting its efficiency in transdermal delivery. This study developed a novel delivery system for retinal (RAL) using flexible liposomes (FLPs) infused with α-tocopherol succinate (α-TS) to improve stability, and enhance skin permeability. The RAL-FLPs were embedded in pressure-sensitive adhesive (PSA) hydrogels, creating a delivery platform that supports prolonged skin residence and efficient permeation of RAL. The stability and skin permeation as well as human skin irritation and adhesion capabilities were assessed to determine the formulation's safety and efficacy. Our findings suggested that the addition of α-TS could improve liposomal stability and RAL chemical stability. Moreover, the skin permeation and fluorescence microscopic-based studies suggested that the addition of α-TS could enhance skin permeability of RAL through hair follicles. The RAL-FLP was embedded in PSA hydrogels fabricated from 25% Gantrez S-97 (GT) and 1% hyaluronic acid (Hya) with aluminum as a crosslinker. The PSA hydrogel exhibited desirable peeling and tacking strengths. The developed hydrogels also demonstrated greater skin deposition of RAL compared with its aqueous formulation. Additionally, the RAL-FLP-embedded PSA hydrogels showed no skin irritation and maintained better adhesion for up to 24 h compared to commercial patches. Hence, the developed hydrogels could serve as a beneficial platform for delivering RAL in treating skin conditions.
视黄醛(RAL),即视网膜醛,是一种维生素A衍生物,广泛用于多种皮肤疾病。然而,它对光敏感且水溶性低,限制了其透皮给药的效率。本研究开发了一种新型的视黄醛(RAL)递送系统,使用注入了琥珀酸生育酚(α-TS)的柔性脂质体(FLP)来提高稳定性并增强皮肤渗透性。将RAL-FLP包埋在压敏胶(PSA)水凝胶中,创建了一个支持RAL在皮肤中长期留存和有效渗透的递送平台。评估了其稳定性、皮肤渗透性以及对人体皮肤的刺激性和黏附能力,以确定该制剂的安全性和有效性。我们的研究结果表明,添加α-TS可以提高脂质体稳定性和RAL的化学稳定性。此外,基于皮肤渗透和荧光显微镜的研究表明,添加α-TS可以通过毛囊增强RAL的皮肤渗透性。RAL-FLP包埋在由25%的甘胆树胶S-97(GT)和1%的透明质酸(Hya)制成的PSA水凝胶中,以铝作为交联剂。该PSA水凝胶表现出理想的剥离强度和粘性强度。与水性制剂相比,所开发的水凝胶还显示出RAL在皮肤中的沉积量更大。此外,与市售贴剂相比,包埋有RAL-FLP的PSA水凝胶没有皮肤刺激性,并且在长达24小时内保持了更好的黏附性。因此,所开发的水凝胶可以作为一种有益的平台,用于递送RAL以治疗皮肤疾病。